Multiple Sclerosis Trial, Recruiting (NCT06937723)

Multiple Sclerosis Trial, Recruiting NCT06937723 Sponsor: Heinrich-Heine University, Duesseldorf Condition: Multiple Sclerosis

Printed from Voxsanity (voxsanity.com.au) — NCT06937723 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Multiple Sclerosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years of age or older
You have been diagnosed with multiple sclerosis (MS) based on the 2017 McDonald criteria
You have muscle stiffness or spasms (spasticity) that your doctor believes needs medical treatment
You own and regularly use a smartphone that runs Android 8.1 or newer, or iOS 12.3 or newer
You are able to use a smartphone independently

Who may not be able to join:

You have not given your written agreement (informed consent) to take part in the study
You are unwilling or unable to use a smartphone app as part of the study
You have another health condition that affects your ability to understand the study or complete it fully — for example, certain mental health conditions or dementia (the trial team will make this decision on a case-by-case basis)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 12 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0049 21181-17889

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06937723

Sponsor: Heinrich-Heine University, Duesseldorf

Phase: Not Applicable

Status: Recruiting

Condition: Multiple Sclerosis

Trial contact: 0049 21181-17889

More information: https://clinicaltrials.gov/study/NCT06937723

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years of age or older
You have been diagnosed with multiple sclerosis (MS) based on the 2017 McDonald criteria
You have muscle stiffness or spasms (spasticity) that your doctor believes needs medical treatment
You own and regularly use a smartphone that runs Android 8.1 or newer, or iOS 12.3 or newer
You are able to use a smartphone independently

Who may not be able to join:

You have not given your written agreement (informed consent) to take part in the study
You are unwilling or unable to use a smartphone app as part of the study
You have another health condition that affects your ability to understand the study or complete it fully — for example, certain mental health conditions or dementia (the trial team will make this decision on a case-by-case basis)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 12 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Heinrich-Heine University, Duesseldorf

Registry

ClinicalTrials.gov

Start date

19 October 2023

Est. completion

1 July 2025

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Wearing time of smartwatch (daily); Longitudinal development of activity parameter: step count; Longitudinal development of activity parameter: approximate distance traveled (meter); Longitudinal development of activity parameter: duration of soft activity (seconds) defined by Withings Description: Examples for soft activity: Sleeping, Sitting quietly, Walking slowly, Typing on a computer keyboard while seated, Watching television; Longitudinal development of activity parameter: duration of moderate activity (seconds) defined by Withings Description: Examples for moderate activity: Walking fas...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov